MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 171 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,436 | -99.8% | 43,260 | +101.1% | 0.02% | +185.7% |
| Q2 2022 | $654,000 | +129.5% | 21,515 | +95.7% | 0.01% | +250.0% |
| Q1 2022 | $285,000 | +36.4% | 10,995 | +7.1% | 0.00% | +100.0% |
| Q4 2021 | $209,000 | -45.7% | 10,264 | -48.8% | 0.00% | -50.0% |
| Q3 2021 | $385,000 | +179.0% | 20,036 | +37.7% | 0.00% | -71.4% |
| Q3 2019 | $138,000 | – | 14,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |